Christopher Labos: Why Aspirin isn't routinely prescribed for cancer prevention

Studies are conflicting, there's no consensus on dosage, and we have an alternative way to prevent cancer that is probably more effective.

In my last column, I tried to make the case that people without a history of cardiovascular disease shouldn’t be taking baby Aspirin because the cardiovascular benefits are largely counterbalanced by the increased risk of bleeding. But one reader contacted me questioning why I had not mentioned the cancer benefit, since he had spent years taking a daily Aspirin for expressly that purpose.  Read More